{"gene":"FOXS1","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2005,"finding":"Foxs1 knockout mice (Foxs1beta-gal/beta-gal) show improved rotarod performance and reduced body weight gain on high-fat diet, with increased UCP1 mRNA; Foxs1 is expressed in dorsomedial hypothalamic neurons, cerebellar internal granule layer, dorsal root ganglia, CNS blood vessel pericytes and smooth muscle cells, establishing a role in motor function and energy homeostasis.","method":"Knock-in/knockout mouse model (beta-galactosidase reporter), rotarod behavioral assay, body weight measurement, UCP1 mRNA quantification","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined behavioral and molecular phenotypes, multiple readouts","pmids":["15964817"],"is_preprint":false},{"year":2007,"finding":"Foxs1 expression marks early sensory neuron precursors across both placode- and neural crest-derived lineages; Foxs1 expression is mutually exclusive with Sox10 in multipotent neural crest cells, defining a sequential emergence of sensory neuron precursors during DRG development.","method":"Immunofluorescence, in situ hybridization, lineage tracing in mouse embryos","journal":"Differentiation; research in biological diversity","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional context, single lab","pmids":["17309606"],"is_preprint":false},{"year":2008,"finding":"Fkhl18 (mouse ortholog of FOXS1/FoxS subfamily) is expressed in periendothelial cells of fetal testis; its knockout causes apoptosis of periendothelial cells (via caspase-3 activation) and vascular gaps; Fkhl18 suppresses FoxO3a and FoxO4 transcriptional activity, and its absence elevates FoxO-driven Fas ligand expression.","method":"Knockout mouse generation, electron microscopy, caspase-3 immunostaining, transcriptional activity assays","journal":"Molecular reproduction and development","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with defined cellular phenotype and transcriptional suppression assay, single lab","pmids":["18288644"],"is_preprint":false},{"year":2017,"finding":"FOXS1 is upregulated by IFNT2 and IFNTc1 in bovine endometrial epithelial cells; FOXS1 knockdown in IFNT-treated cells down-regulates IRF3 and IRF9 and up-regulates STAT1, STAT2, and IRF8, placing FOXS1 as a regulator of interferon signaling genes in endometrium.","method":"RNA-seq, siRNA knockdown, RT-PCR in primary bovine endometrial epithelial cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined transcriptional phenotype, multiple gene targets confirmed","pmids":["28199372"],"is_preprint":false},{"year":2018,"finding":"FOXS1 overexpression in gastric cancer cell lines suppresses cell proliferation, metastasis, and EMT, and decreases β-catenin, c-Myc, and cyclin-D1 expression, while FOXS1 knockdown has opposite effects, placing FOXS1 as a negative regulator of the Wnt/β-catenin pathway.","method":"Overexpression and knockdown in gastric cancer cell lines, Western blot for pathway markers, xenograft mouse model","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional modulation (OE and KD) with pathway readouts in vitro and in vivo","pmids":["30500980"],"is_preprint":false},{"year":2019,"finding":"GLI1 directly binds the FOXS1 promoter and decreases FOXS1 expression; miR-125a-5p represses FOXS1 at the translational level by binding the 3'UTR of FOXS1; NFKB1 indirectly inhibits FOXS1 via its promoter motif; FOXS1 promotes gastric cancer cell proliferation and EMT.","method":"Promoter-reporter assay, ChIP, 3'UTR luciferase assay, siRNA/overexpression, GSEA","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1–2 — direct promoter binding (ChIP) and 3'UTR binding confirmed, single lab","pmids":["30918291"],"is_preprint":false},{"year":2021,"finding":"CD90low glioma-associated MSCs secrete IL-6 to increase FOXS1 expression in glioma cells; elevated FOXS1 activates EMT and promotes temozolomide resistance; FOXS1 knockdown reverses these effects both in vitro and in vivo.","method":"Conditioned media experiments, gene microarray, lentiviral overexpression/knockdown, flow cytometry, xenograft mouse model","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 — paracrine mechanism with IL-6 identified, bidirectional modulation in vitro and in vivo","pmids":["34256854"],"is_preprint":false},{"year":2022,"finding":"FOXS1 transcriptionally upregulates CXCL8 in colorectal cancer cells; CXCL8 knockdown blocks FOXS1-induced EMT and angiogenesis, and FOXS1 expression correlates with CXCL8 and CD31 levels in clinical samples.","method":"siRNA knockdown, RT-PCR, Western blot, tube formation assay, CAM assay, orthotopic mouse model, IHC in clinical samples","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via CXCL8 KD reversing FOXS1 phenotype, in vitro and in vivo","pmids":["35898871"],"is_preprint":false},{"year":2023,"finding":"FOXS1 physically binds Gli1 and inhibits Gli1 ubiquitination, thereby stabilizing Gli1 and activating Hedgehog signaling to promote prostate cancer cell growth and metastasis; Gli1 overexpression or Hh pathway activation reverses the effects of FOXS1 silencing.","method":"Co-IP, ubiquitination assay, siRNA knockdown, Gli1 overexpression, nude mouse tumorigenesis model","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus functional epistasis rescue, single lab","pmids":["37890593"],"is_preprint":false},{"year":2024,"finding":"TGFβ induces FOXS1 expression in hepatic stellate cells (HSCs); FOXS1 CRISPR KO in LX2 cells attenuates over 400 TGFβ-responsive transcripts, and controls pathways mediating TGFβ responsiveness, protein translation, and proliferation as determined by RNA-seq and kinase activity profiling.","method":"CRISPR KO in LX2 HSCs, RNA-seq, PamGene kinase activity assay, RT-qPCR, murine fibrosis model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — CRISPR KO with transcriptome-wide readout and orthogonal kinase activity assay, in vitro and in vivo","pmids":["38280429"],"is_preprint":false},{"year":2024,"finding":"FOXS1 directly interacts with HILPDA in prostate cancer cells; this interaction activates the FAK/PI3K/AKT pathway and promotes EMT; modulating FOXS1 expression bidirectionally alters cell growth, migration, and invasion.","method":"Co-IP, Western blot, CCK-8, wound-healing, Transwell assays, bioinformatics, IHC in clinical samples","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP confirms binding, pathway activation measured by Western blot, single lab","pmids":["38780613"],"is_preprint":false},{"year":2024,"finding":"ADSC-derived extracellular vesicles reduce FOXS1 expression in TGF-β1-treated renal tubular cells, attenuating Wnt/β-catenin pathway activation and EMT; FOXS1 overexpression promotes and knockdown reduces renal fibrosis.","method":"RNA-seq of HK-2 cells, RT-qPCR, Western blot, siRNA/overexpression, UUO mouse model in vivo","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional modulation with pathway readouts in vitro and in vivo","pmids":["39709913"],"is_preprint":false},{"year":2025,"finding":"TGFβ1 induces FOXS1 expression in human adipose stem cells; FOXS1 potentiates TGFβ1-dependent upregulation of myofibroblast genes (Acta2, Col1a1, Fn1, Il11) and suppresses adipogenic genes (Pparg, Stat5a, Fabp4, Adipoq); loss of endogenous FOXS1 improves adipogenic permissiveness even under TGFβ1 stimulation.","method":"TGFβ1 stimulation of primary human ASCs and 10T1/2 fibroblasts, FOXS1 overexpression and loss-of-function, qPCR/Western blot for downstream genes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional gain/loss-of-function with defined gene program readouts, single lab","pmids":["40774386"],"is_preprint":false},{"year":2025,"finding":"FOXS1 directly interacts with TGFBI protein and promotes its degradation via the autophagy-lysosome pathway (not ubiquitin-proteasome); FOXS1 facilitates the interaction between TGFBI and LAMP2A for lysosomal translocation; FOXS1 also regulates AKT phosphorylation and FOXO3a nuclear translocation to promote autophagy-related gene transcription; restoration of TGFBI reverses FOXS1-mediated growth suppression in CRC cells.","method":"Co-IP, GFP-LC3 puncta, Ad-mCherry-GFP-LC3B autophagy flux assay, protein stability analysis, immunofluorescence, Western blot, RNA-seq, in vivo subcutaneous tumor model","journal":"Journal of advanced research","confidence":"High","confidence_rationale":"Tier 1–2 — Co-IP for protein interaction, multiple orthogonal autophagy assays, epistasis rescue, in vivo validation","pmids":["39864590"],"is_preprint":false},{"year":2025,"finding":"In aortic valve interstitial cells, oxLDL induces FOXS1 which directly binds the BSCL2 promoter (ChIP-seq); FOXS1-driven BSCL2 expression inhibits ABCA1 and ABCG1 via the PPARγ/LXRα axis, causing cholesterol transport dysfunction and NLRP3 inflammasome activation, thereby promoting osteogenic differentiation and aortic valve calcification; Foxs1 deletion in Apoe−/− mice reduces aortic valve calcification.","method":"ChIP-seq, RNA-seq, Bodipy-cholesterol transport assay, siRNA/adenoviral modulation of FOXS1 in VICs, Apoe−/−Foxs1−/− mouse model on HFD","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-seq for direct promoter binding, orthogonal cholesterol assay, in vivo KO mouse model with functional outcome","pmids":["40990096"],"is_preprint":false}],"current_model":"FOXS1 is a forkhead box transcription factor expressed in neural crest derivatives, sensory neurons, and pericytes that regulates motor function and energy homeostasis in vivo; it acts as a TGFβ-responsive transcriptional effector that promotes myofibroblast activation, EMT, and fibrosis while suppressing adipogenesis; it directly binds and stabilizes Gli1 by blocking ubiquitination (activating Hedgehog signaling), directly interacts with TGFBI to route it for lysosomal degradation via LAMP2A (promoting autophagy and tumor suppression in colorectal cancer), and directly binds the BSCL2 promoter to suppress cholesterol transporters ABCA1/ABCG1 via PPARγ/LXRα, linking oxLDL signaling to NLRP3 inflammasome activation and aortic valve calcification."},"narrative":{"teleology":[{"year":2005,"claim":"Establishing that FOXS1 has in vivo physiological roles beyond a generic transcription factor, Foxs1 knockout mice revealed functions in motor coordination and energy homeostasis, with expression mapped to hypothalamic neurons, cerebellar neurons, DRG, and CNS pericytes.","evidence":"Foxs1 knock-in/knockout mouse with β-gal reporter; rotarod, body weight, and UCP1 mRNA assays","pmids":["15964817"],"confidence":"High","gaps":["Downstream transcriptional targets mediating motor and metabolic phenotypes not identified","Mechanism linking pericyte expression to energy homeostasis unknown","No conditional knockout to dissect tissue-specific contributions"]},{"year":2007,"claim":"FOXS1 was placed in the developmental context of sensory neurogenesis, marking early sensory neuron precursors across neural crest and placode lineages in a pattern mutually exclusive with Sox10 in multipotent progenitors.","evidence":"Immunofluorescence, in situ hybridization, and lineage tracing in mouse embryos","pmids":["17309606"],"confidence":"Medium","gaps":["Functional requirement for FOXS1 in sensory neuron specification not tested by loss-of-function","Relationship between FOXS1 expression and downstream sensory fate genes unknown"]},{"year":2008,"claim":"A vascular survival function was identified: Foxs1 knockout causes apoptosis of periendothelial cells in fetal testis through derepression of FoxO3a/FoxO4, elevating FasL-mediated cell death.","evidence":"Knockout mouse with EM, caspase-3 immunostaining, and FoxO transcriptional activity assays","pmids":["18288644"],"confidence":"Medium","gaps":["Direct DNA-binding targets mediating FoxO suppression not mapped","Whether vascular phenotype extends beyond fetal testis not tested","Single lab observation"]},{"year":2017,"claim":"FOXS1 was linked to interferon signaling regulation in endometrial epithelial cells, where it modulates expression of IRF3, IRF9, STAT1, and STAT2 downstream of interferon-tau stimulation.","evidence":"siRNA knockdown with RT-PCR validation in IFNT-treated primary bovine endometrial epithelial cells","pmids":["28199372"],"confidence":"Medium","gaps":["Whether FOXS1 directly binds promoters of interferon pathway genes not tested","Bovine-specific context; relevance to human interferon signaling unconfirmed"]},{"year":2018,"claim":"FOXS1 was identified as a tumor suppressor in gastric cancer that negatively regulates the Wnt/β-catenin pathway, decreasing β-catenin, c-Myc, and cyclin-D1 and suppressing EMT.","evidence":"Bidirectional overexpression/knockdown in gastric cancer cell lines with Western blot and xenograft validation","pmids":["30500980"],"confidence":"Medium","gaps":["Mechanism of Wnt pathway suppression (direct binding vs. indirect) not resolved","Contrasts with later findings showing FOXS1 as pro-EMT in other cancer types"]},{"year":2019,"claim":"Upstream regulation of FOXS1 was mapped: GLI1 directly binds the FOXS1 promoter to repress it, and miR-125a-5p post-transcriptionally represses FOXS1 via its 3′UTR; in this gastric cancer context FOXS1 promoted rather than suppressed proliferation and EMT.","evidence":"ChIP for GLI1 at FOXS1 promoter, 3′UTR luciferase assay, siRNA/overexpression in gastric cancer lines","pmids":["30918291"],"confidence":"Medium","gaps":["Context-dependent tumor-suppressive vs. oncogenic roles of FOXS1 not mechanistically reconciled","GLI1 repression of FOXS1 contrasts with later finding of FOXS1 stabilizing GLI1 protein"]},{"year":2021,"claim":"A paracrine mechanism was identified whereby glioma-associated mesenchymal stem cells secrete IL-6 to induce FOXS1 in glioma cells, driving EMT and temozolomide resistance.","evidence":"Conditioned media, gene microarray, lentiviral overexpression/knockdown, xenograft model","pmids":["34256854"],"confidence":"Medium","gaps":["Direct transcriptional targets of FOXS1 in glioma not mapped","Whether IL-6–FOXS1 axis operates in other tumor types unknown"]},{"year":2022,"claim":"A direct transcriptional target in colorectal cancer was identified: FOXS1 upregulates CXCL8, which mediates FOXS1-driven EMT and angiogenesis.","evidence":"CXCL8 knockdown epistasis reversing FOXS1 phenotype; tube formation, CAM, orthotopic mouse model, clinical IHC","pmids":["35898871"],"confidence":"Medium","gaps":["Whether FOXS1 directly binds the CXCL8 promoter not confirmed by ChIP","Contribution of other FOXS1 targets to angiogenesis not excluded"]},{"year":2023,"claim":"A non-transcriptional mechanism was uncovered: FOXS1 physically binds Gli1 protein and blocks its ubiquitination, stabilizing Gli1 to activate Hedgehog signaling in prostate cancer.","evidence":"Co-IP, ubiquitination assay, Gli1 overexpression rescue of FOXS1 knockdown, nude mouse model","pmids":["37890593"],"confidence":"Medium","gaps":["The E3 ligase whose activity is blocked by FOXS1 binding is not identified","Structural basis of FOXS1–Gli1 interaction unknown","Single lab; reciprocal IP not described in detail"]},{"year":2024,"claim":"FOXS1 was established as a central TGFβ-responsive transcriptional effector: CRISPR knockout in hepatic stellate cells attenuated >400 TGFβ-responsive transcripts, and FOXS1 controls pathways of TGFβ responsiveness, translation, and proliferation. Concurrently, FOXS1 was shown to promote renal fibrosis via Wnt/β-catenin and EMT, and to interact with HILPDA to activate FAK/PI3K/AKT in prostate cancer.","evidence":"CRISPR KO in LX2 cells with RNA-seq and PamGene kinase profiling; bidirectional modulation in HK-2 renal cells and UUO mouse model; Co-IP for HILPDA in prostate cancer lines","pmids":["38280429","39709913","38780613"],"confidence":"High","gaps":["Direct FOXS1 chromatin-binding sites genome-wide in stellate cells not mapped by ChIP-seq","Whether FOXS1–HILPDA interaction is direct or mediated through a complex is unclear","Mechanism by which FOXS1 activates Wnt/β-catenin in renal fibrosis not resolved"]},{"year":2025,"claim":"Multiple direct mechanisms of FOXS1 were resolved: (1) FOXS1 interacts with TGFBI and routes it for LAMP2A-dependent lysosomal degradation, promoting autophagy and suppressing CRC growth via AKT/FOXO3a; (2) FOXS1 directly binds the BSCL2 promoter to suppress cholesterol efflux via PPARγ/LXRα, activating NLRP3 inflammasome and aortic valve calcification; (3) FOXS1 potentiates TGFβ1-driven myofibroblast programs while suppressing adipogenesis in adipose stem cells.","evidence":"Co-IP and LAMP2A interaction assays, LC3 autophagy flux, in vivo CRC model; ChIP-seq for BSCL2, cholesterol transport assay, Apoe−/−Foxs1−/− mouse; TGFβ1 gain/loss-of-function in primary human ASCs","pmids":["39864590","40990096","40774386"],"confidence":"High","gaps":["Whether the TGFBI-degradation and Gli1-stabilization functions of FOXS1 share a common protein-interaction domain is unknown","Genome-wide direct transcriptional targets of FOXS1 across tissues remain incompletely catalogued","Structural basis for FOXS1 binding to BSCL2 promoter versus other forkhead sites not resolved"]},{"year":null,"claim":"The context-dependent switching of FOXS1 between tumor-suppressive (gastric cancer, CRC) and oncogenic (glioma, prostate cancer) functions remains mechanistically unexplained, and no comprehensive ChIP-seq map of direct FOXS1 binding sites across tissues exists.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure or domain-resolution interaction mapping for FOXS1","Tissue-specific cofactors that determine pro- vs. anti-tumorigenic activity not identified","Post-translational regulation of FOXS1 protein stability largely unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,7,9,12,14]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,14]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,8,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5,9,14]}],"pathway":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,8,10,11,14]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[9,12,14]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,5,6,7,8,10]}],"complexes":[],"partners":["GLI1","TGFBI","HILPDA","LAMP2A","FOXO3A","BSCL2"],"other_free_text":[]},"mechanistic_narrative":"FOXS1 is a forkhead box transcription factor that functions as a TGFβ-responsive transcriptional effector regulating fibrosis, EMT, energy homeostasis, and cholesterol metabolism across multiple tissue contexts. In hepatic stellate cells and adipose stem cells, TGFβ induces FOXS1 expression, which drives myofibroblast gene programs (Acta2, Col1a1, Fn1, Il11) while suppressing adipogenic transcription factors, and FOXS1 knockout attenuates hundreds of TGFβ-responsive transcripts [PMID:38280429, PMID:40774386]. Beyond its transcriptional roles, FOXS1 engages in direct protein–protein interactions: it binds and stabilizes Gli1 by blocking its ubiquitination to activate Hedgehog signaling [PMID:37890593], interacts with TGFBI to route it for LAMP2A-dependent lysosomal degradation thereby promoting autophagy and tumor suppression in colorectal cancer [PMID:39864590], and directly binds the BSCL2 promoter to suppress cholesterol transporters ABCA1/ABCG1 via the PPARγ/LXRα axis, linking oxLDL signaling to NLRP3 inflammasome activation and aortic valve calcification [PMID:40990096]. Foxs1 knockout mice display improved motor coordination and resistance to diet-induced obesity with elevated UCP1, consistent with roles in hypothalamic energy regulation and pericyte/vascular cell survival [PMID:15964817, PMID:18288644]."},"prefetch_data":{"uniprot":{"accession":"O43638","full_name":"Forkhead box protein S1","aliases":["Forkhead-like 18 protein","Forkhead-related transcription factor 10","FREAC-10"],"length_aa":330,"mass_kda":35.4,"function":"Transcriptional repressor that suppresses transcription from the FASLG, FOXO3 and FOXO4 promoters. May have a role in the organization of the testicular vasculature (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O43638/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FOXS1","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FOXS1","total_profiled":1310},"omim":[{"mim_id":"602939","title":"FORKHEAD BOX S1; FOXS1","url":"https://www.omim.org/entry/602939"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":48.7}],"url":"https://www.proteinatlas.org/search/FOXS1"},"hgnc":{"alias_symbol":["FREAC10"],"prev_symbol":["FKHL18"]},"alphafold":{"accession":"O43638","domains":[{"cath_id":"1.10.10.10","chopping":"24-102","consensus_level":"high","plddt":94.151,"start":24,"end":102}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43638","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43638-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43638-F1-predicted_aligned_error_v6.png","plddt_mean":63.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FOXS1","jax_strain_url":"https://www.jax.org/strain/search?query=FOXS1"},"sequence":{"accession":"O43638","fasta_url":"https://rest.uniprot.org/uniprotkb/O43638.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43638/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43638"}},"corpus_meta":[{"pmid":"15964817","id":"PMC_15964817","title":"Lack of the central nervous system- and neural crest-expressed forkhead gene Foxs1 affects motor function and body weight.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15964817","citation_count":48,"is_preprint":false},{"pmid":"17309606","id":"PMC_17309606","title":"Emergence of the sensory nervous system as defined by Foxs1 expression.","date":"2007","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/17309606","citation_count":42,"is_preprint":false},{"pmid":"34256854","id":"PMC_34256854","title":"CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.","date":"2021","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34256854","citation_count":31,"is_preprint":false},{"pmid":"30918291","id":"PMC_30918291","title":"FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30918291","citation_count":25,"is_preprint":false},{"pmid":"18288644","id":"PMC_18288644","title":"Importance of forkhead transcription factor Fkhl18 for development of testicular vasculature.","date":"2008","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/18288644","citation_count":21,"is_preprint":false},{"pmid":"28199372","id":"PMC_28199372","title":"Endometrial factors similarly induced by IFNT2 and IFNTc1 through transcription factor FOXS1.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28199372","citation_count":14,"is_preprint":false},{"pmid":"30500980","id":"PMC_30500980","title":"Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30500980","citation_count":14,"is_preprint":false},{"pmid":"38280429","id":"PMC_38280429","title":"FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38280429","citation_count":13,"is_preprint":false},{"pmid":"35898871","id":"PMC_35898871","title":"FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35898871","citation_count":13,"is_preprint":false},{"pmid":"37890593","id":"PMC_37890593","title":"FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway.","date":"2023","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37890593","citation_count":10,"is_preprint":false},{"pmid":"38780613","id":"PMC_38780613","title":"FOXS1 acts as an oncogene and induces EMT through FAK/PI3K/AKT pathway by upregulating HILPDA in prostate cancer.","date":"2024","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/38780613","citation_count":6,"is_preprint":false},{"pmid":"39709913","id":"PMC_39709913","title":"Adipose mesenchymal stem cell-derived extracellular vesicles alleviate renal fibrosis by reducing epithelial-mesenchymal transition via the FOXS1/Wnt/β-catenin signaling pathway.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39709913","citation_count":5,"is_preprint":false},{"pmid":"40990096","id":"PMC_40990096","title":"Oxidized LDL-induced FOXS1 mediates cholesterol transport dysfunction and inflammasome activation to drive aortic valve calcification.","date":"2025","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/40990096","citation_count":1,"is_preprint":false},{"pmid":"40774386","id":"PMC_40774386","title":"TGF-β1-dependent expression of FOXS1 attenuates adipogenic potential and enhances a myofibroblast cellular phenotype.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40774386","citation_count":0,"is_preprint":false},{"pmid":"39864590","id":"PMC_39864590","title":"FOXS1, frequently inactivated by promoter methylation, inhibited colorectal cancer cell growth by promoting TGFBI degradation through autophagy-lysosome pathway.","date":"2025","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/39864590","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10434,"output_tokens":3741,"usd":0.043708},"stage2":{"model":"claude-opus-4-6","input_tokens":7222,"output_tokens":3379,"usd":0.180877},"total_usd":0.224585,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Foxs1 knockout mice (Foxs1beta-gal/beta-gal) show improved rotarod performance and reduced body weight gain on high-fat diet, with increased UCP1 mRNA; Foxs1 is expressed in dorsomedial hypothalamic neurons, cerebellar internal granule layer, dorsal root ganglia, CNS blood vessel pericytes and smooth muscle cells, establishing a role in motor function and energy homeostasis.\",\n      \"method\": \"Knock-in/knockout mouse model (beta-galactosidase reporter), rotarod behavioral assay, body weight measurement, UCP1 mRNA quantification\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral and molecular phenotypes, multiple readouts\",\n      \"pmids\": [\"15964817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Foxs1 expression marks early sensory neuron precursors across both placode- and neural crest-derived lineages; Foxs1 expression is mutually exclusive with Sox10 in multipotent neural crest cells, defining a sequential emergence of sensory neuron precursors during DRG development.\",\n      \"method\": \"Immunofluorescence, in situ hybridization, lineage tracing in mouse embryos\",\n      \"journal\": \"Differentiation; research in biological diversity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional context, single lab\",\n      \"pmids\": [\"17309606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Fkhl18 (mouse ortholog of FOXS1/FoxS subfamily) is expressed in periendothelial cells of fetal testis; its knockout causes apoptosis of periendothelial cells (via caspase-3 activation) and vascular gaps; Fkhl18 suppresses FoxO3a and FoxO4 transcriptional activity, and its absence elevates FoxO-driven Fas ligand expression.\",\n      \"method\": \"Knockout mouse generation, electron microscopy, caspase-3 immunostaining, transcriptional activity assays\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined cellular phenotype and transcriptional suppression assay, single lab\",\n      \"pmids\": [\"18288644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FOXS1 is upregulated by IFNT2 and IFNTc1 in bovine endometrial epithelial cells; FOXS1 knockdown in IFNT-treated cells down-regulates IRF3 and IRF9 and up-regulates STAT1, STAT2, and IRF8, placing FOXS1 as a regulator of interferon signaling genes in endometrium.\",\n      \"method\": \"RNA-seq, siRNA knockdown, RT-PCR in primary bovine endometrial epithelial cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined transcriptional phenotype, multiple gene targets confirmed\",\n      \"pmids\": [\"28199372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FOXS1 overexpression in gastric cancer cell lines suppresses cell proliferation, metastasis, and EMT, and decreases β-catenin, c-Myc, and cyclin-D1 expression, while FOXS1 knockdown has opposite effects, placing FOXS1 as a negative regulator of the Wnt/β-catenin pathway.\",\n      \"method\": \"Overexpression and knockdown in gastric cancer cell lines, Western blot for pathway markers, xenograft mouse model\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional modulation (OE and KD) with pathway readouts in vitro and in vivo\",\n      \"pmids\": [\"30500980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GLI1 directly binds the FOXS1 promoter and decreases FOXS1 expression; miR-125a-5p represses FOXS1 at the translational level by binding the 3'UTR of FOXS1; NFKB1 indirectly inhibits FOXS1 via its promoter motif; FOXS1 promotes gastric cancer cell proliferation and EMT.\",\n      \"method\": \"Promoter-reporter assay, ChIP, 3'UTR luciferase assay, siRNA/overexpression, GSEA\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — direct promoter binding (ChIP) and 3'UTR binding confirmed, single lab\",\n      \"pmids\": [\"30918291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD90low glioma-associated MSCs secrete IL-6 to increase FOXS1 expression in glioma cells; elevated FOXS1 activates EMT and promotes temozolomide resistance; FOXS1 knockdown reverses these effects both in vitro and in vivo.\",\n      \"method\": \"Conditioned media experiments, gene microarray, lentiviral overexpression/knockdown, flow cytometry, xenograft mouse model\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — paracrine mechanism with IL-6 identified, bidirectional modulation in vitro and in vivo\",\n      \"pmids\": [\"34256854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FOXS1 transcriptionally upregulates CXCL8 in colorectal cancer cells; CXCL8 knockdown blocks FOXS1-induced EMT and angiogenesis, and FOXS1 expression correlates with CXCL8 and CD31 levels in clinical samples.\",\n      \"method\": \"siRNA knockdown, RT-PCR, Western blot, tube formation assay, CAM assay, orthotopic mouse model, IHC in clinical samples\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via CXCL8 KD reversing FOXS1 phenotype, in vitro and in vivo\",\n      \"pmids\": [\"35898871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FOXS1 physically binds Gli1 and inhibits Gli1 ubiquitination, thereby stabilizing Gli1 and activating Hedgehog signaling to promote prostate cancer cell growth and metastasis; Gli1 overexpression or Hh pathway activation reverses the effects of FOXS1 silencing.\",\n      \"method\": \"Co-IP, ubiquitination assay, siRNA knockdown, Gli1 overexpression, nude mouse tumorigenesis model\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus functional epistasis rescue, single lab\",\n      \"pmids\": [\"37890593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TGFβ induces FOXS1 expression in hepatic stellate cells (HSCs); FOXS1 CRISPR KO in LX2 cells attenuates over 400 TGFβ-responsive transcripts, and controls pathways mediating TGFβ responsiveness, protein translation, and proliferation as determined by RNA-seq and kinase activity profiling.\",\n      \"method\": \"CRISPR KO in LX2 HSCs, RNA-seq, PamGene kinase activity assay, RT-qPCR, murine fibrosis model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — CRISPR KO with transcriptome-wide readout and orthogonal kinase activity assay, in vitro and in vivo\",\n      \"pmids\": [\"38280429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOXS1 directly interacts with HILPDA in prostate cancer cells; this interaction activates the FAK/PI3K/AKT pathway and promotes EMT; modulating FOXS1 expression bidirectionally alters cell growth, migration, and invasion.\",\n      \"method\": \"Co-IP, Western blot, CCK-8, wound-healing, Transwell assays, bioinformatics, IHC in clinical samples\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP confirms binding, pathway activation measured by Western blot, single lab\",\n      \"pmids\": [\"38780613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ADSC-derived extracellular vesicles reduce FOXS1 expression in TGF-β1-treated renal tubular cells, attenuating Wnt/β-catenin pathway activation and EMT; FOXS1 overexpression promotes and knockdown reduces renal fibrosis.\",\n      \"method\": \"RNA-seq of HK-2 cells, RT-qPCR, Western blot, siRNA/overexpression, UUO mouse model in vivo\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional modulation with pathway readouts in vitro and in vivo\",\n      \"pmids\": [\"39709913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TGFβ1 induces FOXS1 expression in human adipose stem cells; FOXS1 potentiates TGFβ1-dependent upregulation of myofibroblast genes (Acta2, Col1a1, Fn1, Il11) and suppresses adipogenic genes (Pparg, Stat5a, Fabp4, Adipoq); loss of endogenous FOXS1 improves adipogenic permissiveness even under TGFβ1 stimulation.\",\n      \"method\": \"TGFβ1 stimulation of primary human ASCs and 10T1/2 fibroblasts, FOXS1 overexpression and loss-of-function, qPCR/Western blot for downstream genes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional gain/loss-of-function with defined gene program readouts, single lab\",\n      \"pmids\": [\"40774386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FOXS1 directly interacts with TGFBI protein and promotes its degradation via the autophagy-lysosome pathway (not ubiquitin-proteasome); FOXS1 facilitates the interaction between TGFBI and LAMP2A for lysosomal translocation; FOXS1 also regulates AKT phosphorylation and FOXO3a nuclear translocation to promote autophagy-related gene transcription; restoration of TGFBI reverses FOXS1-mediated growth suppression in CRC cells.\",\n      \"method\": \"Co-IP, GFP-LC3 puncta, Ad-mCherry-GFP-LC3B autophagy flux assay, protein stability analysis, immunofluorescence, Western blot, RNA-seq, in vivo subcutaneous tumor model\",\n      \"journal\": \"Journal of advanced research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — Co-IP for protein interaction, multiple orthogonal autophagy assays, epistasis rescue, in vivo validation\",\n      \"pmids\": [\"39864590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In aortic valve interstitial cells, oxLDL induces FOXS1 which directly binds the BSCL2 promoter (ChIP-seq); FOXS1-driven BSCL2 expression inhibits ABCA1 and ABCG1 via the PPARγ/LXRα axis, causing cholesterol transport dysfunction and NLRP3 inflammasome activation, thereby promoting osteogenic differentiation and aortic valve calcification; Foxs1 deletion in Apoe−/− mice reduces aortic valve calcification.\",\n      \"method\": \"ChIP-seq, RNA-seq, Bodipy-cholesterol transport assay, siRNA/adenoviral modulation of FOXS1 in VICs, Apoe−/−Foxs1−/− mouse model on HFD\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-seq for direct promoter binding, orthogonal cholesterol assay, in vivo KO mouse model with functional outcome\",\n      \"pmids\": [\"40990096\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FOXS1 is a forkhead box transcription factor expressed in neural crest derivatives, sensory neurons, and pericytes that regulates motor function and energy homeostasis in vivo; it acts as a TGFβ-responsive transcriptional effector that promotes myofibroblast activation, EMT, and fibrosis while suppressing adipogenesis; it directly binds and stabilizes Gli1 by blocking ubiquitination (activating Hedgehog signaling), directly interacts with TGFBI to route it for lysosomal degradation via LAMP2A (promoting autophagy and tumor suppression in colorectal cancer), and directly binds the BSCL2 promoter to suppress cholesterol transporters ABCA1/ABCG1 via PPARγ/LXRα, linking oxLDL signaling to NLRP3 inflammasome activation and aortic valve calcification.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FOXS1 is a forkhead box transcription factor that functions as a TGFβ-responsive transcriptional effector regulating fibrosis, EMT, energy homeostasis, and cholesterol metabolism across multiple tissue contexts. In hepatic stellate cells and adipose stem cells, TGFβ induces FOXS1 expression, which drives myofibroblast gene programs (Acta2, Col1a1, Fn1, Il11) while suppressing adipogenic transcription factors, and FOXS1 knockout attenuates hundreds of TGFβ-responsive transcripts [PMID:38280429, PMID:40774386]. Beyond its transcriptional roles, FOXS1 engages in direct protein–protein interactions: it binds and stabilizes Gli1 by blocking its ubiquitination to activate Hedgehog signaling [PMID:37890593], interacts with TGFBI to route it for LAMP2A-dependent lysosomal degradation thereby promoting autophagy and tumor suppression in colorectal cancer [PMID:39864590], and directly binds the BSCL2 promoter to suppress cholesterol transporters ABCA1/ABCG1 via the PPARγ/LXRα axis, linking oxLDL signaling to NLRP3 inflammasome activation and aortic valve calcification [PMID:40990096]. Foxs1 knockout mice display improved motor coordination and resistance to diet-induced obesity with elevated UCP1, consistent with roles in hypothalamic energy regulation and pericyte/vascular cell survival [PMID:15964817, PMID:18288644].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing that FOXS1 has in vivo physiological roles beyond a generic transcription factor, Foxs1 knockout mice revealed functions in motor coordination and energy homeostasis, with expression mapped to hypothalamic neurons, cerebellar neurons, DRG, and CNS pericytes.\",\n      \"evidence\": \"Foxs1 knock-in/knockout mouse with β-gal reporter; rotarod, body weight, and UCP1 mRNA assays\",\n      \"pmids\": [\"15964817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets mediating motor and metabolic phenotypes not identified\", \"Mechanism linking pericyte expression to energy homeostasis unknown\", \"No conditional knockout to dissect tissue-specific contributions\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"FOXS1 was placed in the developmental context of sensory neurogenesis, marking early sensory neuron precursors across neural crest and placode lineages in a pattern mutually exclusive with Sox10 in multipotent progenitors.\",\n      \"evidence\": \"Immunofluorescence, in situ hybridization, and lineage tracing in mouse embryos\",\n      \"pmids\": [\"17309606\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional requirement for FOXS1 in sensory neuron specification not tested by loss-of-function\", \"Relationship between FOXS1 expression and downstream sensory fate genes unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"A vascular survival function was identified: Foxs1 knockout causes apoptosis of periendothelial cells in fetal testis through derepression of FoxO3a/FoxO4, elevating FasL-mediated cell death.\",\n      \"evidence\": \"Knockout mouse with EM, caspase-3 immunostaining, and FoxO transcriptional activity assays\",\n      \"pmids\": [\"18288644\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct DNA-binding targets mediating FoxO suppression not mapped\", \"Whether vascular phenotype extends beyond fetal testis not tested\", \"Single lab observation\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"FOXS1 was linked to interferon signaling regulation in endometrial epithelial cells, where it modulates expression of IRF3, IRF9, STAT1, and STAT2 downstream of interferon-tau stimulation.\",\n      \"evidence\": \"siRNA knockdown with RT-PCR validation in IFNT-treated primary bovine endometrial epithelial cells\",\n      \"pmids\": [\"28199372\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FOXS1 directly binds promoters of interferon pathway genes not tested\", \"Bovine-specific context; relevance to human interferon signaling unconfirmed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"FOXS1 was identified as a tumor suppressor in gastric cancer that negatively regulates the Wnt/β-catenin pathway, decreasing β-catenin, c-Myc, and cyclin-D1 and suppressing EMT.\",\n      \"evidence\": \"Bidirectional overexpression/knockdown in gastric cancer cell lines with Western blot and xenograft validation\",\n      \"pmids\": [\"30500980\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Wnt pathway suppression (direct binding vs. indirect) not resolved\", \"Contrasts with later findings showing FOXS1 as pro-EMT in other cancer types\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Upstream regulation of FOXS1 was mapped: GLI1 directly binds the FOXS1 promoter to repress it, and miR-125a-5p post-transcriptionally represses FOXS1 via its 3′UTR; in this gastric cancer context FOXS1 promoted rather than suppressed proliferation and EMT.\",\n      \"evidence\": \"ChIP for GLI1 at FOXS1 promoter, 3′UTR luciferase assay, siRNA/overexpression in gastric cancer lines\",\n      \"pmids\": [\"30918291\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context-dependent tumor-suppressive vs. oncogenic roles of FOXS1 not mechanistically reconciled\", \"GLI1 repression of FOXS1 contrasts with later finding of FOXS1 stabilizing GLI1 protein\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A paracrine mechanism was identified whereby glioma-associated mesenchymal stem cells secrete IL-6 to induce FOXS1 in glioma cells, driving EMT and temozolomide resistance.\",\n      \"evidence\": \"Conditioned media, gene microarray, lentiviral overexpression/knockdown, xenograft model\",\n      \"pmids\": [\"34256854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional targets of FOXS1 in glioma not mapped\", \"Whether IL-6–FOXS1 axis operates in other tumor types unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A direct transcriptional target in colorectal cancer was identified: FOXS1 upregulates CXCL8, which mediates FOXS1-driven EMT and angiogenesis.\",\n      \"evidence\": \"CXCL8 knockdown epistasis reversing FOXS1 phenotype; tube formation, CAM, orthotopic mouse model, clinical IHC\",\n      \"pmids\": [\"35898871\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FOXS1 directly binds the CXCL8 promoter not confirmed by ChIP\", \"Contribution of other FOXS1 targets to angiogenesis not excluded\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A non-transcriptional mechanism was uncovered: FOXS1 physically binds Gli1 protein and blocks its ubiquitination, stabilizing Gli1 to activate Hedgehog signaling in prostate cancer.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, Gli1 overexpression rescue of FOXS1 knockdown, nude mouse model\",\n      \"pmids\": [\"37890593\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The E3 ligase whose activity is blocked by FOXS1 binding is not identified\", \"Structural basis of FOXS1–Gli1 interaction unknown\", \"Single lab; reciprocal IP not described in detail\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"FOXS1 was established as a central TGFβ-responsive transcriptional effector: CRISPR knockout in hepatic stellate cells attenuated >400 TGFβ-responsive transcripts, and FOXS1 controls pathways of TGFβ responsiveness, translation, and proliferation. Concurrently, FOXS1 was shown to promote renal fibrosis via Wnt/β-catenin and EMT, and to interact with HILPDA to activate FAK/PI3K/AKT in prostate cancer.\",\n      \"evidence\": \"CRISPR KO in LX2 cells with RNA-seq and PamGene kinase profiling; bidirectional modulation in HK-2 renal cells and UUO mouse model; Co-IP for HILPDA in prostate cancer lines\",\n      \"pmids\": [\"38280429\", \"39709913\", \"38780613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct FOXS1 chromatin-binding sites genome-wide in stellate cells not mapped by ChIP-seq\", \"Whether FOXS1–HILPDA interaction is direct or mediated through a complex is unclear\", \"Mechanism by which FOXS1 activates Wnt/β-catenin in renal fibrosis not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Multiple direct mechanisms of FOXS1 were resolved: (1) FOXS1 interacts with TGFBI and routes it for LAMP2A-dependent lysosomal degradation, promoting autophagy and suppressing CRC growth via AKT/FOXO3a; (2) FOXS1 directly binds the BSCL2 promoter to suppress cholesterol efflux via PPARγ/LXRα, activating NLRP3 inflammasome and aortic valve calcification; (3) FOXS1 potentiates TGFβ1-driven myofibroblast programs while suppressing adipogenesis in adipose stem cells.\",\n      \"evidence\": \"Co-IP and LAMP2A interaction assays, LC3 autophagy flux, in vivo CRC model; ChIP-seq for BSCL2, cholesterol transport assay, Apoe−/−Foxs1−/− mouse; TGFβ1 gain/loss-of-function in primary human ASCs\",\n      \"pmids\": [\"39864590\", \"40990096\", \"40774386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the TGFBI-degradation and Gli1-stabilization functions of FOXS1 share a common protein-interaction domain is unknown\", \"Genome-wide direct transcriptional targets of FOXS1 across tissues remain incompletely catalogued\", \"Structural basis for FOXS1 binding to BSCL2 promoter versus other forkhead sites not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The context-dependent switching of FOXS1 between tumor-suppressive (gastric cancer, CRC) and oncogenic (glioma, prostate cancer) functions remains mechanistically unexplained, and no comprehensive ChIP-seq map of direct FOXS1 binding sites across tissues exists.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure or domain-resolution interaction mapping for FOXS1\", \"Tissue-specific cofactors that determine pro- vs. anti-tumorigenic activity not identified\", \"Post-translational regulation of FOXS1 protein stability largely unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 7, 9, 12, 14]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 14]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 8, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5, 9, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 8, 10, 11, 14]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [9, 12, 14]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 5, 6, 7, 8, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GLI1\",\n      \"TGFBI\",\n      \"HILPDA\",\n      \"LAMP2A\",\n      \"FOXO3A\",\n      \"BSCL2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}